Maternal death by cancer in pregnancy: A descriptive study of the International Network on Cancer, Infertility and Pregnancy
Related Experiment Video
Updated: Jun 23, 2025

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
Joosje H Heimovaara1,2, Evangeline A Huis In 't Veld2,3, Christianne A R Lok2
1Department of Oncology, KU Leuven, Leuven, Belgium.
Objective:
To characterise pregnant women diagnosed with primary or recurrent cancer who died during pregnancy, during delivery or within 1 year postpartum.
Design:
A descriptive study.
Setting:
The registry of the International Network on Cancer, Infertility and Pregnancy (INCIP).
Population:
Women diagnosed with cancer during pregnancy between 2000 and 2022.
Methods:
Using the INCIP registry database, we compared the characteristics of all women with cancer who died during pregnancy, delivery or within 1 year postpartum with those of all women with cancer who survived the first year postpartum.
Main Outcome Measures:
Maternal and tumour characteristics and obstetrical and neonatal outcomes.
Results:
Of the 2359 women registered in INCIP, there were 131 cases (5.6%) of maternal mortality. Lung cancer (9/14, 64.3% of all registered women with lung cancer), gastro-oesophageal cancer (13/21, 61.9%) and acute leukaemia (17/105, 16.2%) had the highest rates of maternal mortality. Maternal mortality was associated with fewer live births compared with the control group without maternal mortality (99/131, 75.6%, vs 1952/2163, 90.0%; P < 0.001), more elective caesarean sections (64/104, 60.4%, vs 756/1836, 41.2%; P < 0.001) and a lower gestational age at (induced) delivery (34.0 vs 37.1 weeks; P < 0.001), resulting in more preterm births.
Conclusions:
Maternal mortality occurred in 5.6% of cancer-in-pregnancy cases and is associated with adverse perinatal outcomes.
More Related Videos
05:16Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Related Concept Videos
Teratogenicity
Cancer Survival Analysis
Disorders of the Female Reproductive System
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of...
Nondisjunction
Cancer Prevention
Some...